✦ LIBER ✦

Rapid reversion of eosinophilic gastroenteritis associated with FIP1L1-PDGFRA fusion after targeted therapy with imatinib

✍ Scribed by Vincenzo Pitini; Giuseppe Sturniolo; Vittorio Cavallari; Carmela Arrigo

Book ID: 108673385
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 150 KB
Volume: 132
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2005.05698.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Complete reversal of left ventricular ma

Complete reversal of left ventricular mass in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia after therapy with Imatinib

✍ Hans C. Volz; Celine Weiss; Dirk Loβnitzer; Alexandra R. Zankl; Jolanta B. Perz; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 492 KB

Maintenance therapy with imatinib appear

Maintenance therapy with imatinib appears necessary despite molecular remission in FIP1L1-PDGFRA fusion gene positive hypereosinophilic disorder

✍ Heng Joo Ng; Daryl C.L. Tan; Richard C. Yiu; Gee Fung How 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Complete cytogenetic remission in a pati

Complete cytogenetic remission in a patient with FIP1L1-PDGFRA fusion negative chronic eosinophilic leukemia associated with atypical thrombotic events

✍ A. Zabernigg; M. Erdel; R. Schranzhofer; K. Berek; K. Gattringer 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 172 KB

Chronic eosinophilic leukaemia with FIP1

Chronic eosinophilic leukaemia with FIP1L1–PDGFRA fusion and T674I mutation that evolved from Langerhans cell histiocytosis with eosinophilia after chemotherapy

✍ Hiroaki Ohnishi; Koji Kandabashi; Yoshiharu Maeda; Machiko Kawamura; Takashi Wat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB

Clinical characteristics of patients wit

Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript—results of Polish multicentre study

✍ Grzegorz Helbig; Andrzej Moskwa; Marek Hus; Jarosław Piszcz; Alina Swiderska; Al 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

## Abstract A small subgroup of patients with hypereosinophilic syndrome (HES) demonstrates imatinib‐sensitive fusion transcript—the FIP1L1‐PDGFRA (F/P+). These cases are currently diagnosed as chronic eosinophilic leukaemia (CEL). In this paper, we screened 77 patients to estimate the frequency of

Durable remission after treatment with v

Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia

✍ Grzegorz Helbig; Andrzej Moskwa; Marek Hus; Jarosław Piszcz; Alina Swiderska; Al 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 147 KB